Literature DB >> 17210404

Endovascular repair of an iliac artery aneurysm in a patient with Ehlers-Danlos syndrome type IV.

Britt H Tonnessen1, W Charles Sternbergh, Krishna Mannava, Samuel R Money.   

Abstract

Ehlers-Danlos type IV (EDS-IV) is an inherited condition most notable for its associated vascular complications. Patients are prone to aneurysm formation, arterial dissection, and spontaneous vessel rupture. Intervention for the vascular pathology of EDS-IV carries high morbidity and mortality. We describe a case of a 57-year-old man with EDS-IV and an expanding iliac aneurysm who underwent successful endovascular repair with a stent-graft. Endovascular aneurysm repair is feasible and should be considered for patients with EDS-IV.

Entities:  

Mesh:

Year:  2007        PMID: 17210404     DOI: 10.1016/j.jvs.2006.08.071

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  2 in total

1.  A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.

Authors:  Sherene Shalhub; Peter H Byers; Kelli L Hicks; Kristofer Charlton-Ouw; Devin Zarkowsky; Dawn M Coleman; Frank M Davis; Ellen S Regalado; Giovanni De Caridi; K Nicole Weaver; Erin M Miller; Marc L Schermerhorn; Katie Shean; Gustavo Oderich; Mauricio Ribeiro; Cole Nishikawa; Christian-Alexander Behrendt; E Sebastian Debus; Yskert von Kodolitsch; Richard J Powell; Melanie Pepin; Dianna M Milewicz; Peter F Lawrence; Karen Woo
Journal:  J Vasc Surg       Date:  2019-05-21       Impact factor: 4.268

2.  Visceral artery aneurysms: Incidence, management, and outcome analysis in a tertiary care center over one decade.

Authors:  Michael B Pitton; Evelyn Dappa; Florian Jungmann; Roman Kloeckner; Sebastian Schotten; Gesine M Wirth; Jens Mittler; Hauke Lang; Peter Mildenberger; Karl-Friedrich Kreitner; Katja Oberholzer; Christoph Dueber
Journal:  Eur Radiol       Date:  2015-02-19       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.